ResMed Inc. (RSMDF) Research

ResMed Inc. is a leading global medical technology company specializing in the development, manufacturing, and distribution of medical devices and digital health solutions for the healthcare sector. Its operations are divided into two primary segments: Sleep and Respiratory Care, and Software as a Service (SaaS). The Sleep and Respiratory Care division offers a comprehensive range of products addressing various respiratory disorders. This includes advanced technologies for medical and consumer applications, ventilation devices, diagnostic tools, mask systems for both hospital and home use, headgear, other accessories, and dental devices. This segment also incorporates cloud-based informatics software designed to improve patient outcomes. Specific digital health offerings include AirView, a cloud-based system enabling remote monitoring and adjustment of patient device settings; myAir, a personalized therapy management application for sleep apnea patients providing support, education, and troubleshooting; and U-Sleep, a compliance monitoring solution that helps home medical equipment (HME) providers optimize their sleep programs. Additionally, ResMed offers connectivity modules, Propeller solutions, and the Propeller portal. Through its Software as a Service segment, ResMed delivers a suite of out-of-hospital software solutions. These comprise Brightree, a business management software and service platform for providers of HME, pharmacy, home infusion, orthotics, and prosthetics; MatrixCare, which offers comprehensive care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, alongside related accountable care organizations; and HEALTHCAREfirst, providing electronic health record (EHR) software, billing and coding services, and analytics for home health and hospice agencies. ResMed markets its extensive product line to sleep clinics, home healthcare dealers, and hospitals. The company utilizes a network of distributors and a direct sales force to reach customers in approximately 140 countries globally. Founded in 1989, ResMed Inc. maintains its headquarters in San Diego, California.

Market snapshot

Symbol
RSMDF
Price
$16.99
Day change
0.00%
Market cap
$27.4B
P/E ratio
18.17x
52-week range
11.85-28.25
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 1 month

Peer companies

  • Coloplast A/S (CLPBF)
  • Coloplast A/S (CLPBY)
  • Daiichi Sankyo Company, Limited (DSKYF)
  • Fresenius SE & Co. KGaA (FSNUF)
  • Haleon plc (HLNCF)
  • HOYA Corporation (HOCPF)
  • Terumo Corporation (TRUMF)
  • Terumo Corporation (TRUMY)

Recent insider activity

  • Farrell Michael J. — M-Exempt (4991 shares) on 2026-06-08
  • Farrell Michael J. — S-Sale (4991 shares) on 2026-06-08
  • Farrell Michael J. — M-Exempt (4991 shares) on 2026-06-08
  • Farrell Michael J. — M-Exempt (4991 shares) on 2026-05-07
  • Farrell Michael J. — S-Sale (4991 shares) on 2026-05-07

Open ResMed Inc. (RSMDF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.